Behavioral Science, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Qual Life Res. 2011 Dec;20(10):1543-53. doi: 10.1007/s11136-011-0004-7. Epub 2011 Sep 11.
To examine evidence of QOL response shift in patients with multiple sclerosis (MS) using recursive partitioning tree analysis (RPART) technique.
MS patients from the NARCOMS registry assessed an average of 6 times at a median interval of 6 months.
SF-12v2 Physical & Mental Component Scores (PCS, MCS). Covariates: Patient-determined disease steps, Performance Scales, and symptomatic therapies. RPART trees were fitted separately by 3 disease-trajectory groups: (1) relapsing (n = 1,582); (2) stable (n = 787); and (3) progressive (n = 639). The resulting trees were interpreted by identifying salient terminal nodes that showed the unexpected quantitative patterns of contrasting MCS and PCS scores (e.g., PCS deteriorates but MCS is stable or improves), using a minimally important difference of at least 5 points on the SF-12v2. Qualitative indicators of response shift were different thresholds (recalibration), content (reconceptualization), and order (reprioritization) of disability domains in predicting PCS change by group.
Overall, 20% of patients demonstrated response shift quantitatively, with 10% in the "progressive" cohort, 8% in the "relapsing" cohort, and 2% in the "stable" cohort. RPART trees differed qualitatively across disease-trajectory groups in patterns suggestive of recalibration, reprioritization, and reconceptualization. Disability subscales, but not symptom management, distinguished homogenous groups.
PCS and MCS change scores are obfuscated by response shifts. The contingent true scores for PCS change scores are not comparable across patient groups.
使用递归分区树分析(RPART)技术检查多发性硬化症(MS)患者生活质量(QOL)反应转移的证据。
来自 NARCOMS 登记处的 MS 患者平均评估 6 次,中位数间隔为 6 个月。
SF-12v2 生理和心理成分评分(PCS、MCS)。协变量:患者确定的疾病阶段、表现量表和症状治疗。RPART 树分别根据 3 种疾病轨迹组进行拟合:(1)复发(n=1582);(2)稳定(n=787);(3)进展(n=639)。通过识别具有显著终端节点的方法来解释生成的树,这些节点显示了出人意料的相反 MCS 和 PCS 分数的定量模式(例如,PCS 恶化但 MCS 稳定或改善),SF-12v2 上至少有 5 分的最小重要差异。反应转移的定性指标是不同的阈值(再校准)、残疾领域的内容(重新概念化)和顺序(重新优先排序),用于预测不同组的 PCS 变化。
总体而言,20%的患者表现出定量反应转移,其中 10%在“进展”队列中,8%在“复发”队列中,2%在“稳定”队列中。RPART 树在疾病轨迹组之间存在明显差异,表明存在再校准、重新优先排序和重新概念化。残疾子量表,而不是症状管理,可以区分同质组。
PCS 和 MCS 变化分数受到反应转移的混淆。PCS 变化分数的 contingent 真实分数在不同患者组之间不可比较。